File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Lignans: Quantitative Analysis of the Research Literature

TitleLignans: Quantitative Analysis of the Research Literature
Authors
Keywordslignans
pharmacology
chemistry
plant science
cancer
Issue Date2020
PublisherFrontiers Research Foundation. The Journal's web site is located at http://www.frontiersin.org/pharmacology
Citation
Frontiers in Pharmacology, 2020, v. 11, p. article no. 37 How to Cite?
AbstractThe current study provides a comprehensive overview and analysis of the lignan literature. Data for the current study were extracted from the electronic Web of Science Core Collection database via the search string TOPIC = (“lignan*”) and processed by the VOSviewer software. The search yielded 10,742 publications. The ratio of original articles to reviews was 14.6:1. Over 80% of the analyzed papers have been published since the year 2000 and nearly 50% since the year 2010. Many of the publications were focused on pharmacology, chemistry, and plant sciences. The United States and Asian countries, such as China, Japan, South Korea, and India, were the most productive producers of lignan publications. Among the 5 most productive institutions was the University of Helsinki in Finland, the country that ranked 9th. Nineteen journals collectively published 3,607 lignan publications and were considered as core journals. Their impact factor did not correlate with the proportion of uncited papers. Highly cited publications usually mentioned phytoestrogen, isoflavone, daidzein, enterodiol, enterolactone, equol, genistein, and isoflavonoid. Cancer (e.g., breast cancer), cardiovascular disease, and antioxidation were the major themes. Clinical trials were estimated to contribute to 0.2–1.1% of the analyzed body of literature, so more of them should be conducted in the future to substantiate the beneficial effects and optimal dose of lignan intake in humans. Moreover, researchers can refer to these findings for future research directions and collaborations.
Persistent Identifierhttp://hdl.handle.net/10722/280963
ISSN
2019 Impact Factor: 4.225
2015 SCImago Journal Rankings: 1.845

 

DC FieldValueLanguage
dc.contributor.authorYeung, AWK-
dc.contributor.authorTzvetkov, NT-
dc.contributor.authorBalacheva, AA-
dc.contributor.authorGeorgieva, MG-
dc.contributor.authorGan, RY-
dc.contributor.authorJozwik, A-
dc.contributor.authorPyzel, B-
dc.contributor.authorHorbańczuk, JO-
dc.contributor.authorNovellino, E-
dc.contributor.authorDurazzo, A-
dc.contributor.authorLucarini, M-
dc.contributor.authorCamilli, E-
dc.contributor.authorSouto, EB-
dc.contributor.authorAtanasov, AG-
dc.contributor.authorSantini, A-
dc.date.accessioned2020-02-25T07:43:20Z-
dc.date.available2020-02-25T07:43:20Z-
dc.date.issued2020-
dc.identifier.citationFrontiers in Pharmacology, 2020, v. 11, p. article no. 37-
dc.identifier.issn1663-9812-
dc.identifier.urihttp://hdl.handle.net/10722/280963-
dc.description.abstractThe current study provides a comprehensive overview and analysis of the lignan literature. Data for the current study were extracted from the electronic Web of Science Core Collection database via the search string TOPIC = (“lignan*”) and processed by the VOSviewer software. The search yielded 10,742 publications. The ratio of original articles to reviews was 14.6:1. Over 80% of the analyzed papers have been published since the year 2000 and nearly 50% since the year 2010. Many of the publications were focused on pharmacology, chemistry, and plant sciences. The United States and Asian countries, such as China, Japan, South Korea, and India, were the most productive producers of lignan publications. Among the 5 most productive institutions was the University of Helsinki in Finland, the country that ranked 9th. Nineteen journals collectively published 3,607 lignan publications and were considered as core journals. Their impact factor did not correlate with the proportion of uncited papers. Highly cited publications usually mentioned phytoestrogen, isoflavone, daidzein, enterodiol, enterolactone, equol, genistein, and isoflavonoid. Cancer (e.g., breast cancer), cardiovascular disease, and antioxidation were the major themes. Clinical trials were estimated to contribute to 0.2–1.1% of the analyzed body of literature, so more of them should be conducted in the future to substantiate the beneficial effects and optimal dose of lignan intake in humans. Moreover, researchers can refer to these findings for future research directions and collaborations.-
dc.languageeng-
dc.publisherFrontiers Research Foundation. The Journal's web site is located at http://www.frontiersin.org/pharmacology-
dc.relation.ispartofFrontiers in Pharmacology-
dc.rightsThis Document is Protected by copyright and was first published by Frontiers. All rights reserved. It is reproduced with permission.-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectlignans-
dc.subjectpharmacology-
dc.subjectchemistry-
dc.subjectplant science-
dc.subjectcancer-
dc.titleLignans: Quantitative Analysis of the Research Literature-
dc.typeArticle-
dc.identifier.emailYeung, AWK: ndyeung@hku.hk-
dc.identifier.authorityYeung, AWK=rp02143-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.3389/fphar.2020.00037-
dc.identifier.hkuros309159-
dc.identifier.volume11-
dc.identifier.spagearticle no. 37-
dc.identifier.epagearticle no. 37-
dc.publisher.placeSwitzerland-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats